10 ML tislelizumab-jsgr 10 MG/ML Injection [Tevimbra]
- RxCUI
- 2677439
- RxNorm name
- 10 ML tislelizumab-jsgr 10 MG/ML Injection [Tevimbra]
- Display name
- 10 ML tislelizumab-jsgr 10 MG/ML Injection [Tevimbra]
- Full name
- 10 ML tislelizumab-jsgr 10 MG/ML Injection [Tevimbra]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761232 | Tevimbra | tislelizumab-jsgr | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TEVIMBRA | TISLELIZUMAB-JSGR | BeOne Medicines USA, Inc. | 08ef1e3e-496f-4b0b-94ee-fbba3cc1985a | 2026-08-31 | Warnings, Adverse reactions | 2677439 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 08ef1e3e-496f-4b0b-94ee-fbba3cc1985a | TEVIMBRA 100 MG in 10 ML Injection [PSN] · 10 ML tislelizumab-jsgr 10 MG/ML Injection [Tevimbra] [SBD] · 10 ML Tevimbra 10 MG/ML Injection [SY] · Tevimbra 100 MG per 10 ML Injection [SY] | 4 | 12 | These highlights do not include all the information needed to use TEVIMBRA safely and effectively. See full prescribing information for TEVIMBRA. TEVIMBRA ® (tislelizumab-jsgr) injection, for intravenous use Initial U.S. Approval: 2024 | 20260204 |